[144] Littelfuse Inc SEC Filing
Form 144 filed for Littelfuse, Inc. (LFUS) documents a proposed sale of 100 common shares through Merrill with an aggregate market value of $25,737.00, with an approximate sale date of 08/15/2025 on NASDAQ. The filer reports that the 100 shares were acquired on 04/23/2020 by exercising stock options granted by Littelfuse, Inc., and payment for the proposed sale is listed as cash. The filing also discloses prior open-market sales by Meenal Sethna on 08/12/2025 (2,923 shares, $745,804 gross), 08/13/2025 (11,256 shares, $2,926,188 gross), and 08/14/2025 (40 shares, $10,331 gross), totaling $3,682,323 in gross proceeds from those three days.
The filer certifies there is no undisclosed material adverse information about the issuer and provides the standard signature/attestation language required by the form.
- None.
- Significant recent insider sales: three open-market sales on 08/12–08/14/2025 produced $3,682,323 in gross proceeds, which is material in absolute dollar terms.
- Concentration of sales over consecutive days: 2,923 and 11,256 shares sold on consecutive dates may attract investor attention regarding insider liquidity.
Insights
TL;DR Recent concentrated insider sales generated approximately $3.68M in gross proceeds; a small additional proposed sale of 100 shares is scheduled for 08/15/2025.
The pattern shows significant open-market dispositions over three consecutive trading days followed by a small proposed sale. The disclosed acquisitions were via stock option exercise on 04/23/2020, so these are routine disposals of previously acquired shares rather than issuer-originated transfers. For investors, the primary data point is the magnitude of realized proceeds of $3,682,323 across 08/12–08/14/2025, which may reflect planned diversification of holdings rather than company-specific news; the filer explicitly attests to absence of undisclosed material adverse information.
TL;DR Multiple days of insider sales totaling multi-million dollars warrant governance notice but are disclosed per Rule 144 requirements.
The filing properly lists the nature of acquisition (stock option exercise) and provides broker and transaction specifics for the proposed sale. The attestation language is present, and dates and amounts for recent sales are clearly reported. From a governance and compliance perspective, the form meets disclosure obligations; the sequence of sales should prompt routine monitoring by investors and compliance officers but does not, by itself, indicate a regulatory deficiency.